Acclarent Inspira AIR Balloon Dilation System Recall

Federal health regulators are warning that defects with the Inspira AIR balloon dilation system could lead to patient deaths. 

The FDA classified an Inspira dilation system recall as a Class I medical device recall on March 13, indicating that the agency believes there is a reasonable probability that problems with the device will cause serious injuries or death.

The Inspira, manufactured by Acclarent, Inc., is an airway balloon catheter used to dilate and restore airflow for patients having problems breathing.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

It has been discovered that the dilation balloon used in the Inspira could fail to deflate or deflate slowly, blocking a patient’s airway until the balloon is deflated or removed. This could lead to temporary, permanent or fatal injuries.

There have been at least four incidents linked to the air balloon dilation problems, one of which resulted in patient injury. In all four cases, the device malfunctioned during surgery, when the balloon moved during dilation and the surgeon tried to pull it into place. The catheter shaft narrowed when the surgeon pulled, preventing the balloon from deflating.

The recall affects the Acclarent Inspira AIR Balloon Dilation System, size 19-x40mm. It was manufactured between March 2011 and June 2011 and has a product code of BC1840A.

The recall was first announced on January 30, in a letter mailed by Acclarent to its customers. The company recommends that customers immediately discontinue use of the Inspira and send them to Stericycle to be recycled. The company has promised to pay a full refund. Customers with questions can call Acclarent at (866) 781-1173.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted today)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 2 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.